Table 3.
Distribution of cytogenetic risk groups
| SG group | Observed (expected) count |
||
|---|---|---|---|
| Favorable | Intermediate | Unfavorable | |
| 1 | 1 (2.83) | 19 (15.84) | 14 (15.33) |
| 2 | 12 (4.17)* | 19 (23.30) | 19 (22.54) |
| 3 | 4 (3.42) | 25 (19.10)* | 12 (18.48)* |
| 4 | 2 (3.25) | 19 (18.17) | 18 (17.58) |
| 5 | 1 (2.67) | 8 (14.91)* | 23 (14.42)* |
| 6 | 2 (2.92) | 21 (16.31)* | 12 (15.78) |
| 7 | 0 (2.75)* | 12 (15.38) | 21 (14.88)* |
The 3 major cytogenetic risk groups are unevenly distributed across the seven protein signature groups. Each cell contains the observed (and expected under the null hypothesis) number of patients in each group.
*
Observations that differed most from the expected values (and thus contributed significantly to the χ2 test).